Clinical Trial

Screen2Prevent (S2P)

Study acronym: S2P
Recruiting
View on ClinicalTrials.gov →
Summary
Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).
Trial Details
NCT Number NCT07728123
Lead Sponsor Westat
Conditions HIV Infections
Enrollment 84,000 participants
Start Date 2026-06-16
Primary Completion 2028-10-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-27